Skip to content
Screener

Glaukos GKOS Deferred Tax Assets

Deferred Tax Assets at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$6.61B+701%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$4.38B+3,141%
AbbVie logo
AbbVieABBV
$137M-94.7%
Schering-Plough logo
Schering-PloughSGP
$173K+188%
Bausch + Lomb logo
Bausch + LombBLCO
$952M-2.2%
Staar Surgical logo
Staar SurgicalSTAA
$1.09M

Other financials

Income statement

See full
Revenue$185.6M+49.5%
Gross profit$151.6M+55.9%
Operating income-$17.3M+23.9%
Net income-$18.4M+6.5%
EPS (diluted)-$0.31+8.8%

Balance sheet

See full
Cash & equivalents$114.5M+13.6%
Total debt$105.9M-1.4%
Total equity$682.5M-10.8%
Total assets$920.5M-6.7%

Cash flow

See full
Operating cash flow$14.8M
CapEx$2.7M+132%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$10.09B+98.7%
Enterprise value$10.08B+98.3%
P/S16.5×+4.7×

Profitability

See full
Gross margin61%-15.4pp
Operating margin-31.6%+22.2pp
Net margin-30.7%+23.3pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26%-11,301pp
Debt / equity0.2×0.0×
Current ratio-0.5×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The source filing: Glaukos’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324201
Line itemJune 30, 2026December 31, 2025
Total current liabilities102,329101,275
Operating lease liability35,49135,767
Finance lease liability67,34568,109
Deferred tax liability, net441441
Other liabilities32,42931,740
Total liabilities238,035237,332
Commitments and contingencies (Note 11)
Stockholders' equity:

Item 1. Financial Statements

FAQ

What is Glaukos's deferred tax assets?
Glaukos (GKOS) reported deferred tax assets of $441K in Q2 2026.
How has Glaukos's deferred tax assets changed year-over-year?
Glaukos's deferred tax assets decreased by 93.6% year-over-year, from $6.91M to $441K.
What is the long-term trend for Glaukos's deferred tax assets?
Over 5 years (2020 to 2025), Glaukos's deferred tax assets has grown at a -47.0% compound annual growth rate (CAGR), from $10.51M to $441K.
What does deferred tax assets mean?
Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.

Ask your AI about Glaukos's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude